Last Updated: 12 April 2019
became the first law firm in the PRC, dating back to 1979, and is one of the largest Chinese law firms, with more than 290 lawyers practising in its Beijing, Shanghai and Shenzhen offices. The pharmaceutical and healthcare (P&H) practice group is one of the leading advisers in China, having provided ... ‘one-stop’ legal services for every area of the P&H industry, including drug R&D, clinical research organisations, pharmaceuticals, life sciences, biotechnology, medical devices, supply producers and distributors, hospitals and other healthcare providers, as well as various investment funds in the P&H sector. Global advises clients on challenging P&H legal issues such as regulatory compliance, structuring transactions and contractual arrangements, realisation of pipeline and geographic expansions, capital raising and project financing, M&A, reorganisations, IP protection, licensing and distribution arrangements, settlement of disputes involving adverse effects in clinical trials and medical treatment. The firm has close links to industrial associations and makes recommendations on industry codes of conduct.
has an Intellectual Property Department made up of more than 20 partners and more than 80 other professionals, and includes both Chinese and Western-trained specialists in patents, trade marks, copyrights and other IP matters. Areas of focus for the team include the review and formulation of ... compliance measures for companies, regulatory matters, investment, financing and M&A, anti-corruption and commercial bribery investigations, dispute resolution, IP rights, and private equity and investment in start-ups. The team has been widely praised for helping Chinese enterprises set foot into the international market, and for helping multinational enterprises enter the Chinese market.